Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

DaVita HealthCare Partners earns over 30 awards for excellence in 2014

DaVita HealthCare Partners Inc., one of the nation's largest and most innovative health care communities, today confirmed earning over 30 awards for excellence from independent organizations in 2014.

1 Dec 2014

Leading experts to discuss specific strategies to combat Ebola

Where do we stand in the fight against Ebola -- and what should be done now?

1 Dec 2014

New vaccine shows promise in patients with metastatic breast cancer

A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients' immune systems to attack tumor cells and helped slow the cancer's progression.

1 Dec 2014

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie.

29 Nov 2014

Health Canada warns Canadians against illegal health products

A vendor in Atlantic Canada (www.health-recovery-info.com) is selling Miracle Mineral Solution (MMS), an unauthorized drug product which Health Canada has previously warned may pose serious risks to health if ingested.

29 Nov 2014

Kessler Institute provides tips to help reduce risk of injury during winter months

Winter appears to have arrived early, bringing with it record snowfalls and cold temperatures across the country. It also brings an increased risk for injuries. Whether shoveling snow, dealing with icy roads, or simply trying to walk on wet, slippery pavement, caution is the key word.

29 Nov 2014

Researchers use mathematical models to predict how immune cells respond to disease

Walter and Eliza Hall Institute researchers have defined for the first time how the size of the immune response is controlled, using mathematical models to predict how powerfully immune cells respond to infection and disease.

28 Nov 2014

New smartphone app may help improve prescribing of antibiotics within RCSI Hospitals Group

A new smartphone app has been developed by the RCSI (Royal College of Surgeons in Ireland) Hospitals Group, in association with the Dublin North East Healthcare-Associated Infection (HCAI) Committee, which will provide healthcare professionals in hospitals within the RCSI Hospitals Group with immediate access to guidelines for antimicrobial prescribing.

27 Nov 2014

Researchers say that nervous system may play vital role in infections, autoimmune diseases

The nervous system may play a bigger role in infections and autoimmune diseases than previously known. If researchers can learn more about that role, it could provide insight into diagnosing and treating everything from the stomach flu to rheumatoid arthritis.

27 Nov 2014

New research brings personalized cancer vaccine approach one step closer to reality

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at Washington University School of Medicine in St. Louis has brought the approach one step closer to reality.

27 Nov 2014

Experimental Ebola vaccine appears safe, produces immune system responses in NIH phase 1 trial

An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial conducted by researchers from the National Institutes of Health. The candidate vaccine, which was co-developed by the NIH's National Institute of Allergy and Infectious Diseases and GlaxoSmithKline, was tested at the NIH Clinical Center in Bethesda, Maryland.

27 Nov 2014

New hybrid vehicle to improve delivery of DNA vaccines is under development

Described recently in the Proceedings of the National Academy of Sciences, the technology is a biomedical advancement that could help unleash the potential of DNA vaccines, which despite two decades of research, have yet to make a significant impact in the treatment of major illnesses.

26 Nov 2014

Isis Pharmaceuticals announces initiation of ISIS-SMN Rx Phase 3 study in children with SMA

Isis Pharmaceuticals, Inc. announced today the initiation of a pivotal Phase 3 study evaluating ISIS-SMNRx in approximately 120 non-ambulatory children with spinal muscular atrophy (SMA).

25 Nov 2014

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

Before reaching for that daily antacid, you might consider what it's doing to the trillions of bugs living in your gut. A new Mayo Clinic study in the open access journal Microbiome shows that people who regularly take proton pump inhibitors (PPIs) have less diversity among their gut bacteria, putting them at increased risk for infections like clostridium difficile and pneumonia, in addition to vitamin deficiencies and bone fractures.

25 Nov 2014

TSRI scientists find simple method to convert human skin cells into sensory neurons

A team led by scientists from The Scripps Research Institute has found a simple method to convert human skin cells into the specialized neurons that detect pain, itch, touch and other bodily sensations. These neurons are also affected by spinal cord injury and involved in Friedreich's ataxia, a devastating and currently incurable neurodegenerative disease that largely strikes children.

25 Nov 2014

Scientists discover that brown fat could be used to manage type 2 diabetes

Scientists from Monash University and Stockholm University have discovered that brown fat, nicknamed the 'good fat' because it warms up the body in cold temperatures, burning up calories in the process, also 'hoovers up' excess sugar.

24 Nov 2014

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

The U.S. Food and Drug Administration has granted qualified infectious disease product (QIDP) designation to two Bayer investigational agents, Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation (DPI).

24 Nov 2014

Tips to reduce risk of Turkey Bowl injuries

Every year around this time, Loyola University Medical Center sports medicine surgeon Dr. Pietro Tonino sees a spike in sprains, contusions, broken bones and other injuries suffered in Thanksgiving pick-up football games.

23 Nov 2014

UCLA creates largest-ever protein that self-assembles into molecular 'cage'

UCLA biochemists have created the largest-ever protein that self-assembles into a molecular "cage." The research could lead to synthetic vaccines that protect people from the flu, HIV and other diseases.

23 Nov 2014

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Clementia Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation for palovarotene, the company's lead product candidate, for the treatment of fibrodysplasia ossificans progressiva (FOP).

21 Nov 2014

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

DaVita HealthCare Partners earns over 30 awards for excellence in 2014

Leading experts to discuss specific strategies to combat Ebola

New vaccine shows promise in patients with metastatic breast cancer

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Health Canada warns Canadians against illegal health products

Kessler Institute provides tips to help reduce risk of injury during winter months

Researchers use mathematical models to predict how immune cells respond to disease

New smartphone app may help improve prescribing of antibiotics within RCSI Hospitals Group

Researchers say that nervous system may play vital role in infections, autoimmune diseases

New research brings personalized cancer vaccine approach one step closer to reality

Experimental Ebola vaccine appears safe, produces immune system responses in NIH phase 1 trial

New hybrid vehicle to improve delivery of DNA vaccines is under development

Isis Pharmaceuticals announces initiation of ISIS-SMN Rx Phase 3 study in children with SMA

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

TSRI scientists find simple method to convert human skin cells into sensory neurons

Scientists discover that brown fat could be used to manage type 2 diabetes

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

Tips to reduce risk of Turkey Bowl injuries

UCLA creates largest-ever protein that self-assembles into molecular 'cage'

Clementia gets Orphan Medicinal Product Designation from EMA for palovarotene

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in